ISPOR - Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients

Full Text

Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients

Abstract

Authors

B Wali S Halimeh C Male

Back to Volume 19, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now